Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT05089734 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05089734
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2023-11-29
- Enrollment
- 603
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.